Advertisement

Oncology

Advertisement

Though patient enrollment in clinical trials for cancer therapies has slowed as a result of the COVID-19 pandemic, and some institutions have halted trials altogether, other trials are continuing with modified protocols, according to STAT News.

Advertisement